Allergen extracts - Allergoids - Peptides;Allergenextrakte - Allergoide - Peptide

Allergologie

Volumn 20, Issue 11, 1997, Pages 599-606

  Fiebig, H ^a,b  

^a ALLERGOPHARMA JOACHIM GANZER KG   (Germany)

^b NONE   (Germany)

Author keywords

allergen; allergoid; immunotherapy; TH lymphocytes

Indexed keywords

ALLERGEN; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGY; DESENSITIZATION; HELPER CELL; HUMAN; IMMUNOTHERAPY; REVIEW;

EID: 0030670691     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Baumgarten C., G. Kunkel, R. Rudolph: Vergleichende Untersuchung von Graspollen-Allergikern behandelt mit Graspollen-Allergoid sowie an Aluminiumhydroxid adsorbierten Graspollen-Allergenen. Allergologie 5, 89-96 (1982).
2. Bousquet J., A. Hejjaoui, W. Skassa-Brociek et al.: Double-blind, placebo-controlled immunotherapy with mixed grass pollen allergoid IV. Comparison of the safety and efficacy. J. Allergy Clin. Immunol. 85, 490-497 (1990).
3. Bousquet J., A. Hejjaoui, W. Skassa-Brociek et al.: Double-blind, placebo-controlled immunotherapy with mixed grass pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass pollen extract. J. Allergy Clin. Immunol. 82, 439-446 (1988).
4. Carballido J.M., N. Carballido-Perring, M.K. Kägi, R.H. Meloen, B. Wüthrich, C.H. Heusser, K. Blaser: T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2. J. Immunol. 150, 3582-3591 (1993).
5. Creticos P.S., J. Hebert, G. Philip and the Allervax Ragweed Study Group: Efficacy of Allervay regweed peptides in the treatment of ragweed-induced allergy. J. Allergy Clin. Immunol. 99, 1631 (1997).
6. Ebner C., Z. Szepfalusi, F. Ferreira, A. Jilek, P. Parronchi, E. Maggi, S. Romagnani, O. Scheiner, D. Kraft: Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J. Immunol. 150, 1047-1054 (1993).
7. Fiebig H.: Immunologische Aspekte der spezifischen Immuntherapie (Hyposensibilisierung), Teil I: Die Steuerung der IgE-Synthese. Allergo J. 6, 336-339 (1995).
8. Fiebig H.: Immunologische Aspekte der spezifischen Immuntherapie (Hyposensibilisierung), Teil II: Die Umorientierung der T-Helferzellreaktion. Allergo J. 7, 377-382 (1995).
9. Frank E.: Multicenterstudie zur Bewertung von Wirksamkeit und Verträglichkeit einer Hyposensibilisierungs-Behandlung mit Allergoid-Depot mit Kurzzeit-Dosierungsschema (Allergovit Gräser-/Roggenpollen). Allergologie 1, 23-30 (1987).
10. Gajewski T.F., M. Pinnas, T. Wong, F.W. Fitch: Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 146, 1750 (1991).
11. Ishizaka K., T. Kishimoto, G. Delespesse, T.P. King: Immunogenic properties of modified antigen E.I.: Presence of specific determinants for T cells in denaturated antigen and polypeptide chains. J. Immunol. 113, 70-77 (1974).
12. Jutel M., W.J. Pichler, D. Skrebic: Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J. Immunol. 154, 4187-4194 (1995).
13. Kahlert H., W.-D. Müller, T. Karamfilov, O. Cromwell, H. Fiebig: Reaktion von Allergenen und Allergoiden mit T-Zellinien und T-Zellklonen. Allergo J. 5, 40 (1996).
14. Kumar N., S. Sheikh, M. Zitt, D. Bouboulis, S. Fang, S. Pahwa, M. Frieri, E. Meadow: Allergen-specific interleukin (IL) 4 and interferon-gamma (IFN-γ) production during immunotherapy (IT) in Asthma. J. Allergy Clin. Immunol. 95, 307 (Abstract 667) 1995.
15. Lee W.Y., A.H. Sehon: Suppression of reagenic antibodies with modified allergens. I. Reduction in allergenicity of protein allergens by conjugation to polyethylene glycol. Int. Arch. Allergy Appl. Immunol. 56, 159-170 (1978).
16. Linggood F.V. M.F. Stevens, A.J. Fulthorpe et al.: The toxoiding of purified diphteria toxin. Br. J. Exp. Pathol. 44, 177-188 (1963).
17. Liu F.T., C.A. Bogowitz, R.F. Bargatze, M. Zinnecker, L.R. Katz, D.H. Katz: Immunologic tolerance to allergenic protein determinants: properties of tolerance induced in mice treated with conjugates of protein and synthetic copolymer of d-glutamic acid and d-lysine (d-GI). J. Immunol. 123, 2456-2465 (1979).
18. Loidolt D., H.J. Maasch: Hyposensibilisierung bei Pollinose: Vergleichende klinische und immunologische Untersuchungen mit Allergen-Depot und Allergoid-Depot Allergologie 5, 176-182 (1987).
19. Maasch H.J., D.G. Marsh: Standardized extracts. Modified allergens - allergoids. Clin. Rev. Allergy 5, 89-106 (1987).
20. Malling H.-J., B. Weeke: Position paper: Immunotherapy. Allergy 48, 9-35 (1993).
21. Marsh D.G., L.M. Lichtenstein, D.H. Campbell: Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. Immunology 18, 705-722 (1970).
22. Marsh D.G., P.S. Norman, M. Roebber et al.: Studies on allergoids from naturally occurring allergens III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J. Allergy Clin. Immunol. 68, 449-459 (1981).
23. McHugh S.M., J. Deighton, A.G. Stewart, P.J. Lachmann, P.W. Ewan: Bee venom immunotherapy induces a shift in cytokine responses from a TH2 to a TH1 dominant pattern: comparison of rush and conventional therapy. Clin. Exp. Allergy 25, 828-838 (1995).
24. Moran D.M., A.W., Wheeler: Chemical modification of crude timothy grass pollen extract. I. Antigenicity and immunogenicity changes following amino group modification. Int. Arch. Allergy Appl. Immunol. 50, 693-708 (1976).
25. Mosmann T.R., R.L. Coffman: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7, 145 (1989).
26. Müller U., M. Fricker, C.A. Akdis, J. Carballido, K. Blaser: Successful immunotherapy with T cell epitopes of bee venom phospholipase A2 (PLA) in patients with bee venom (BV) allergy. J. Allergy Clin Immunol. 97, 426 (1996).
27. Müller W.-D., T. Karamfilov, H. Stüwe, H. Kahlert, B. Fahlbusch, O. Cromwell, M. Fiebig, L. Jäger: Mapping of T cell epitopes of Phl p5, a major allergen of timothy grass (Phleum pratense). In press.
28. Noon L.: Prophylactic inoculation against hay fever. Lancet I, 1572-1573 (1911).
29. Norman P.S., J.L. Ohman, A.A. Long, P.S. Creticos, M.L. Gefter, Z. Shaked, R.A. Wood, P.A. Eggleston, L.M. Lichtenstein, N.H. Jones, C.F. Nicodemus: Follow-on study of the first clinical trial with T cell-defined peptides from cat allergen Fel d1. J. Allergy Clin. Immunol. 95, 259 (1995).
30. Norman P.S., J.L. Ohmann, A.A. Long, P.S. Creticos, M. Gefter, Z. Shaked, R.A. Wood, P.A. Eggleston, K.B. Hafner, P. Rao, L.M. Lichtenstein, N.H. Jones, C.F. Nicodemus: Treatment of cat allergy with T cell-reactive peptides. Am. J. Respir. Crit. Care Med. 154, 1623-1628 (1996).
31. O'Hehir R.E., G.F Hoyne, W.R. Thomas, J.R. Lamb: House dust mite allergy: from T cell epitopes to immunotherapy. Eur. J. Clin. Invest. 23, 763-772 (1993).
32. Romagnani S.: Regulation and deregulation of human IgE synthesis. Immunol. Today 11, 316-321 (1990).
33. Romagnani S.: Human TH1 and TH2: doubt no more. Immunol. Today 12, 256 (1991).
34. Secrist H., R. De Kruyff, D.T. Umetsu: Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181, 1081-1089 (1995).
35. Secrist H., C.J. Chelen, Y. Wen, J.D. Marshall, D.T. Umetsu: Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J. Exp. Med. 178, 2123-2130 (1993).
36. Tari M.G., M. Mancino, E. Ghezzi, E. Frank, O. Cromwell: Immunotherapy with an alum-adsorbed parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study. Allergy 52, 65-74 (1997).
37. Wallner B.P., M.L. Gefter: Immunotherapy with T cell-reactive peptides derived from allergens. Allergy 49, 302-308 (1994).
38. Wihl J.A., L. Pilstrom, H.J. Maasch: Studies on allergen and allergoid preparations from purified timothy (Phleum pratense) pollen extracts. III. Comparative investigations by skin prick tests and nasal provocation tests. Int. Arch. Allergy Appl. Immunol. 76, 162-167 (1985).